|
注册号: Registration number: |
ChiCTR2200063219 |
|
最近更新日期: Date of Last Refreshed on: |
2023-04-11 08:53:57 |
|
注册时间: Date of Registration: |
2022-09-01 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
研究者撤销 改良足背静脉皮瓣与动脉皮瓣修复手外伤的临床疗效比较 |
|
Public title: |
Canceled by the investigator. Comparison of curative effects between modified acrotarsium venous flap and arterial flap in the repair of hand injury |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
改良足背静脉皮瓣与动脉皮瓣修复手外伤的临床疗效比较 |
|
Scientific title: |
Comparison of curative effects between modified acrotarsium venous flap and arterial flap in the repair of hand injury |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
钟云雪 |
研究负责人: |
魏在荣 |
|
Applicant: |
Zhong Yunxue |
Study leader: |
Wei Zairong |
|
申请注册联系人电话: Applicant telephone: |
+86 15120310740 |
研究负责人电话:
Study leader's |
+86 15208660008 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
844564235@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
188116999@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
贵州省遵义市汇川区大连路149号 |
研究负责人通讯地址: |
贵州省遵义市汇川区大连路149号 |
|
Applicant address: |
149 Dalian Road, Huichuan District, Zunyi, Guizhou |
Study leader's address: |
149 Dalian Road, Huichuan District, Zunyi, Guizhou |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
遵义医科大学附属医院 |
||
|
Applicant's institution: |
Affiliated Hospital of Zunyi Medical University |
||
|
研究负责人所在单位: |
遵义医科大学附属医院 |
||
|
Affiliation of the Leader: |
Affiliated Hospital of Zunyi Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KLLY-2021-182 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
遵义医科大学附属医院生物医学研究伦理委员会 |
||
|
Name of the ethic committee: |
Biomedical Research Ethics Committee of the Affiliated Hospital of Zunyi Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-12-31 00:00:00 | ||
|
伦理委员会联系人: |
李树飞 |
||
|
Contact Name of the ethic committee: |
Li Shufei |
||
|
伦理委员会联系地址: |
贵州省遵义市汇川区大连路149号行政楼3楼 |
||
|
Contact Address of the ethic committee: |
3rd Floor, Administration Building, 149 Dalian Road, Huichuan District, Zunyi, Guizhou |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
遵义医科大学附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Affiliated Hospital of Zunyi Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
贵州省遵义市汇川区大连路149号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
149 Dalian Road, Huichuan District, Zunyi, Guizhou |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
贵州省科学技术厅项目(2020-5012);贵州省教科技厅函(2020-39) |
||||||||||||||||||||||
|
Source(s) of funding: |
Project of Guizhou Provincial Department of Science and Technology (2020-5012); Letter from Guizhou Provincial Department of Education, Science and Technology (2020-39) |
||||||||||||||||||||||
|
研究疾病: |
手部组织缺损 |
||||||||||||||||||||||
|
Target disease: |
tissue defect of hand |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
预后研究 |
||||||||||||||||||||||
|
Study type: |
Prognosis study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
病例研究 |
||||||||||||||||||||||
|
Study design: |
Case study |
||||||||||||||||||||||
|
研究目的: |
对静脉皮瓣的临床效果进行进一步观察,并同动脉皮瓣修复的手部组织缺损对比预后情况。 |
||||||||||||||||||||||
|
Objectives of Study: |
To further observe the clinical effect of the venous flap and to compare the prognosis with the hand tissue defect repaired by the arterial flap. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.合并重大内科疾病及神经疾病患者; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with major medical diseases and neurological diseases; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-09-01 00:00:00至 To 2023-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-09-01 00:00:00 至 To 2023-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
所有患者入院后均告知两种治疗方法的优缺点,若患者同意,将其纳入,始终由同一个试验参与人员使用SPSS20.0软件对其进行随机分组,第一组采用静脉皮瓣转移修复创面,第二组采用传统皮瓣转移修复创面。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
All patients were informed of the advantages and disadvantages of the two treatment methods after admission. If the patients agreed, they would be included. The same trial participant would always use SPSS20.0 software to randomly group them. The first group used venous flap transfer to repair the wound, an |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
待文章发表后通过电话或邮箱联系作者。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Contact the author by phone or email after publication. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
Excel表,CRF表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Excel Form and Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |